- Home
- TPCS vs BNR Comparison
TPCS vs BNR Comparison
Compare TPCS & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPCS
- BNR
- Stock Information
- Founded
- TPCS 1956
- BNR 2014
- Country
- TPCS United States
- BNR China
- Employees
- TPCS N/A
- BNR N/A
- Industry
- TPCS Metal Fabrications
- BNR Medical Specialities
- Sector
- TPCS Industrials
- BNR Health Care
- Exchange
- TPCS Nasdaq
- BNR Nasdaq
- Market Cap
- TPCS 42.6M
- BNR 38.3M
- IPO Year
- TPCS N/A
- BNR 2020
- Fundamental
- Price
- TPCS $5.83
- BNR $6.90
- Analyst Decision
- TPCS
- BNR
- Analyst Count
- TPCS 0
- BNR 0
- Target Price
- TPCS N/A
- BNR N/A
- AVG Volume (30 Days)
- TPCS 93.7K
- BNR 57.4K
- Earning Date
- TPCS 07-29-2025
- BNR 08-21-2025
- Dividend Yield
- TPCS N/A
- BNR N/A
- EPS Growth
- TPCS N/A
- BNR N/A
- EPS
- TPCS N/A
- BNR N/A
- Revenue
- TPCS $34,031,000.00
- BNR $72,112,038.00
- Revenue This Year
- TPCS N/A
- BNR $136.32
- Revenue Next Year
- TPCS N/A
- BNR N/A
- P/E Ratio
- TPCS N/A
- BNR N/A
- Revenue Growth
- TPCS 7.72
- BNR 0.53
- 52 Week Low
- TPCS $2.05
- BNR $2.18
- 52 Week High
- TPCS $5.94
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- TPCS 75.75
- BNR 58.58
- Support Level
- TPCS $4.02
- BNR $6.03
- Resistance Level
- TPCS $5.94
- BNR $7.80
- Average True Range (ATR)
- TPCS 0.51
- BNR 1.00
- MACD
- TPCS 0.18
- BNR -0.08
- Stochastic Oscillator
- TPCS 95.74
- BNR 32.51
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.